Results of the APACT Study: Phase III Trial of Adjuvant Nab-Paclitaxel

Results of the APACT Study: Phase III Trial of Adjuvant Nab-Paclitaxel

obr

11 months
68 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Thomas A. Abrams, Senior Physician and Assistant Medical Professor at Harvard Medical School provides results about the APACT
Study. APACT Study is a phase III trial of adjuvant nab-paclitaxel plus
gemcitabine versus gemcitabine for surgically resected pancreatic
adenocarcinoma.
Up Next Autoplay